Progyny vs Tempus AI
Progyny reported revenue of $1.3 billion in fiscal 2025, about the same as Tempus AI's $1.3 billion in fiscal 2025. Progyny's revenue grew 10.4% in its latest year, and Tempus AI's grew 83.4%. Progyny had an operating margin of 6.6%, against -19.9% at Tempus AI. Free cash flow was $192 million at Progyny and −$239 million at Tempus AI.
Side by side
| Progyny | Tempus AI | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $1.3B | $1.3B |
| Revenue growth | 10.4% | 83.4% |
| Revenue growth a year, last 5 years | 30.2% | — |
| Gross margin | 23.6% | — |
| Operating margin | 6.6% | −19.9% |
| Net margin | 4.5% | −19.3% |
| Free cash flow | $192M | −$239M |
| Free cash flow margin | 14.9% | −18.8% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $82M | $3M |
| Change in diluted share count | −5.8% | 45.4% |
| Last close | $34.84 | $76.05 |
| P/E at the last close | 32.0× | — |
| Insider trades, last 12 months | bought $1.9 million, sold $2.3 million | sold $208.4 million |
| Piotroski F-score | — | 5 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
ProgynyTempus AI
Operating margin
Percent of revenue
ProgynyTempus AI
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ProgynyTempus AI
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Progyny and Tempus AI pages.